patient
febril
tachycard
heart
rate
beat
per
minut
arteri
oxygen
satur
sao
liter
supplement
oxygen
physic
examin
demonstr
coars
crackl
bilater
lower
lung
field
past
medic
histori
includ
hypertens
diabet
mellitu
differenti
diagnosi
includ
commun
acquir
pneumonia
atyp
pneumonia
laboratori
investig
reveal
leukopenia
kul
elev
lactat
dehydrogenas
ldh
ul
creactiv
protein
mgl
ddimer
level
ngml
rapid
influenza
test
neg
electrocardiogram
ekg
unremark
figur
comput
tomographi
ct
chest
reveal
bilater
interstiti
densiti
consist
infecti
inflammatori
process
evid
pulmonari
embol
figur
start
intraven
fluid
prophylact
dose
enoxaparin
broadspectrum
antibiot
includ
vancomycin
levaquin
cefepim
due
high
suspicion
pneumonia
also
test
follow
day
realtim
fluoresc
polymeras
chain
reaction
return
posit
symptom
improv
support
measur
antibiot
discontinu
plan
made
discharg
home
selfquarantin
howev
prior
discharg
develop
sudden
sever
dyspnea
walk
room
note
hypox
sao
drop
result
oxygen
requir
liter
nasal
patient
start
therapeut
enoxaparin
close
monitor
hemodynam
instabl
declin
take
hydroxychloroquin
recommend
manag
remain
hemodynam
stabl
transit
oral
anticoagul
therapi
apixaban
plan
continu
anticoagul
month
novel
coronaviru
diseas
outbreak
unpreced
global
public
health
challeng
sinc
end
decemb
first
case
novel
sever
acut
respiratori
syndrom
detect
wuhan
china
diseas
spread
exponenti
januari
world
health
organ
declar
diseas
caus
novel
coronaviru
public
health
emerg
intern
concern
pheic
later
offici
upgrad
global
pandem
april
confirm
case
countri
death
document
worldwid
project
unit
state
us
death
toll
greater
estim
total
burden
million
case
approxim
case
fever
common
present
follow
cough
vomit
diarrhea
patient
natur
cours
diseas
complic
sever
interstiti
pneumonia
lead
acut
respiratori
distress
syndrom
ard
multiorgan
failur
includ
acut
kidney
injuri
dissemin
intravascular
coagul
death
knowledg
report
case
complic
massiv
pulmonari
embol
rightsid
heart
failur
epidem
report
incid
deep
venou
thrombosi
pulmonari
embol
affect
patient
respect
far
concret
data
overal
incid
thrombosi
patient
infect
howev
estim
patient
elev
ddimer
level
diseas
progress
directli
associ
risk
increas
thrombosi
poor
prognosi
diseas
multivari
regress
show
increas
odd
inhospit
death
associ
ddimer
greater
higher
risk
vessel
thrombosi
correl
sever
diseas
multiorgan
involv
lead
support
argument
therapeut
anticoagul
patient
elev
ddimer
level
propos
mechan
induc
thrombosi
includ
diseasespecif
hypercoagul
state
cytokinemedi
diffus
microvascular
damag
case
reactiv
thrombocytosi
risk
thrombosi
pulmonari
embol
compound
obes
advanc
age
hospit
relat
immobil
present
case
patient
elev
crp
ddimer
level
risk
factor
pulmonari
embol
indic
relat
hypercoagul
state
possibl
etiolog
thrombosi
pulmonari
vasculatur
patient
remain
asymptomat
episod
breathless
hypoxia
followup
remain
apixaban
plan
follow
hematologist
month
patient
admit
treatment
isol
imper
follow
prophylact
measur
avoid
venou
thromboembol
sudden
deterior
respiratori
statu
explain
signific
radiolog
chang
lung
field
especi
conjunct
high
titer
ddimer
rais
suspicion
pulmonari
embol
studi
need
determin
util
therapeut
dose
anticoagul
highrisk
patient
abl
make
differenti
diagnosi
pulmonari
embol
patient
sudden
onset
dyspnea
hypoxemia
understand
potenti
role
earli
anticoagul
highrisk
patient
